Sysnav provides SV95C, the first regulatory-qualified real-world digital endpoint.
CONTACT
Sysnav Healthcare team smiling in front of a scientific poster on DMD at the International Congress of Myology 2024

News and White papers

The latest news at Sysnav Healthcare

Sysnav Healthcare is committed to advancing Angelman Syndrome Research, one stride at a time!

Events

6 Nov 2023

Sysnav Healthcare Sponsors FAST Summit 2023

Sysnav Healthcare is thrilled to announce its sponsorship of the 16th Annual FAST Global Science Summit from 9th-10th November 2023.
Sysnav Healthcare is participating in the Annual Basel Biometric Society 2023

Events

3 Nov 2023

2023 Basel Biometric Society Meeting

Sysnav Healthcare is thrilled to announce its participation in the 2023 Basel Biometric Society’s Annual Meeting. Damien Eggenspieler, Director of the Healthcare Program, will be our representative at this event.
Sysnav Healthcare is exhibiting in ECTRIMS 2023

Events

9 Oct 2023

Sysnav Healthcare at ECTRIMS-ACTRIMS 2023

Sysnav Healthcare is thrilled to be participating in the 9th Joint ECTRIMS-ACTRIMS Meeting.
SV95C primary qualification as a primary endpoint for clinical trials in DMD

Events

8 Aug 2023

EMA Approves SV95C as Primary Endpoint in DMD

EMA opinion marks the first qualification of a digital outcome measure for use as a primary endpoint in pivotal drug trials
Syde-derived endpoint, SV95C gets acknowledged in HealthXL "Unlocking the Value of Digital Measures in Drug Development"

News

8 Aug 2023

SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95th Centile (SV95C) for Duchenne Muscular Dystrophy 

EMA opinion marks the first qualification of a digital outcome measure for use as a primary endpoint in pivotal drug trials
Sysnav Healthcare announces a multi-year collaboration with Roche based on Sysnav's proprietary movement tracking technology

News

25 Jan 2023

Sysnav Healthcare announces a multi-year collaboration with Roche

The partnership aims to facilitate development of industry standard outcome measurements in diseases associated with movement impairments
CONTACT